---
{"dg-publish":true,"permalink":"/USMLE/Renal/Membranous nephropathy/","tags":["t1"]}
---

# Epidemiology
<span style="background:rgba(240, 200, 0, 0.2)">Most common cause of [[USMLE/Renal/Nephrotic syndrome\|nephrotic syndrome]] in adults of European, Middle Eastern, or North African descent</span>

---
# Etiology
- Primary: <span style="background:rgba(240, 200, 0, 0.2)">anti-PLA2R antibodies</span>
- Secondary:
	- <span style="background:rgba(240, 200, 0, 0.2)">Infections ([[USMLE/GI/Hepatitis B\|HBV]], [[USMLE/GI/Hepatitis C\|HCV]], [[USMLE/Infective disease/Malaria\|malaria]]</span>, [[USMLE/Infective disease/Syphilis\|syphilis]])
	- Autoimmune diseases (e.g., <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Immunology/Systemic lupus erythematosus\|SLE]]</span>)
	- Tumors (e.g., [[USMLE/Respiratory/Lung cancer\|lung cancer]], [[USMLE/Renal/Prostate cancer\|prostate cancer]])
	- Medications (e.g.,<span style="background:rgba(240, 200, 0, 0.2)"> [[USMLE/Pharmacology/Non-opioid analgesics\|NSAIDs]], penicillamine</span>, gold)

---
# Pathophysiology
Anti-phospholipase A2 receptor antibodies (anti-PLA2R antibodies) bind to PLA2R (an autoantigen in glomerular podocytes) and thereby form immune complexes that activate the [[USMLE/Immunology/Complement system\|complement system]], leading to podocyte injury.

---
# Clinical features


---
# Diagnostics
There is diffuse thickening of the glomerular basement membrane and capillaries.![Pasted image 20240810205356.png](/img/user/appendix/Pasted%20image%2020240810205356.png)![Pasted image 20240810205416.png](/img/user/appendix/Pasted%20image%2020240810205416.png)

---
# Treatment


---
